Patent Application
20160034635
Embodiments of the invention relate to predictions of evolutionary fitness of genes in a population of organisms. In particular, some embodiments of the invention relate to the use of genetic variation, whether within a single species or across multiple species, to predict the fitness of hypothetical or virtual offspring associated with a potential mating before that mating occurs.
Every year thousands of babies are born with genetic diseases. Often, the parents of these children are both healthy, but each parent possesses genetic mutations that when passed in combination to the child, endow it from the time of conception with an unmitigated genetic defect. Children with such diseases may suffer, have diminished lifespans and can entail large emotional and financial costs, so many prospective parents attempt to minimize the chance that they pass on genetic elements that cause disease.
Carrier testing, in which both parents are genotyped at loci of their genomes that are known to cause disease, is a technique widely used to achieve this goal. Such tests rely on a defined set of alleles known to cause diseases, and then screen for the presence of these alleles in one or both parents prior to conception. The alleles screened in such tests typically have been established to cause disease by examining pedigrees of patients with the disease, by using cellular or animal models of the effect of the particular allele, or alternate means. In all cases, the correlation between alleles and genetic diseases are determined by studying one or more individuals that have already been born.
Although carrier testing is used in a limited number of cases, even if all possible prospective matings were filtered by this technique, children suffering from genetic diseases would still be born. This is because carrier tests inherently screen only a known subset of all alleles that can cause disease. The incompleteness of these tests is evidenced by the fact that the number of alleles associated with disease in public databases such as ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/) and OMIM (http://www.ncbi.nlm.nih.gov/omim) continues to grow every year, and in turn so do the number of loci tested by carrier screening. Similarly, many patients can present with pathologies which appear to have a genetic basis, but for which no specific underlying genetic mutation has yet been determined. In many of these cases, a novel pathogenic variant or variants is then later discovered by various means and added to the catalog of known disease associated mutations. For example, the genomes of many patients with similar pathologies can be sequenced and shared mutations found. Alternatively, mutations that occur in an individual patient's genome which appear damaging (missense, nonsense, etc.) and are present in genes known to be associated with a biological process related to the pathology, may be tested in a cellular or animal model.
While the steady increase of the catalog of variants known to cause disease implies that carrier testing will get better, it also evinces that it suffers from two fundamental inadequacies. The first is that a diseased child must be born and diagnosed in order to find a new disease associated allele. The second, and more insidious, is that carrier testing cannot assess the impact of novel or de novo mutations. If a variant is specific to an individual or family and has not been previously studied, carrier testing cannot determine what effect it may have on future offspring. Additionally, because novel variants initially only appear as one half of a heterozygote genotype, if the allele is recessive, but damaging when combined with itself or another recessive mutation, it is very difficult to resolve the effect of the mutation until, from the perspective of a parent who wants to avoid passing on disease causing alleles, it is too late.
A system, device and method are described to overcome the aforementioned issues in the art. Some embodiments may assign one or more likelihoods that an allele mutation in a simulated virtual progeny is deleterious based on the evolutionary variation at the allele loci in real extant species or populations, for example, in order to filter out prospective pairings of gametes prior to conception.
According to some embodiments of the invention, a system, device and method may use the evolution of genetic variation of multiple organisms within one species (“single-species” or “intra-species” model) or across multiple different species (“multi-species” or “inter-species” model) to predict the likelihood that alleles would be deleterious in hypothetical, simulated or virtual progeny. Past evolutionary trends in allele mutations of extant or surviving (currently or once-living) organisms representative of one or more species or populations may be analyzed to predict the future fitness of a potential hypothetical or virtual (never or non-living) progeny simulated for two potential parents.
According to some embodiments of the invention, a system, device and method may receive multiple aligned genetic sequences obtained from genetic samples of multiple organisms of one or more different species. Genetic loci are aligned from different sequences for different organisms that are derived from one or more common ancestral genetic loci correlated with the same trait(s), disease(s), codon(s), that are positioned or sandwiched between other correlated marker loci, or that are otherwise related. A measure of evolutionary variation may be computed for one or more alleles at each of one or more aligned genetic loci of the multiple aligned sequences. The measure of evolutionary variation may be a function of variation in alleles at corresponding aligned genetic loci in the multiple aligned genetic sequences. One or more likelihoods may be computed that an allele, either a new mutation or one present in the alignment, at each of the one or more genetic loci in a simulated virtual progeny will be deleterious based on the measure of evolutionary variation of alleles at the corresponding aligned genetic loci for the multiple organisms.
According to some embodiments of the invention, a system, device and method may generate the virtual (hypothetical, potential or non-living) progeny by simulating a mating between two (living) potential parents by combining at least a portion of their genetic information. Simulating a mating may include combining genetic information of both of the two potential parents at one or more genetic loci. In one embodiment, a mating may be simulated by generating a virtual gamete for each potential parent by at least partially randomly selecting one of two allele copies in the parent's two sets of chromosomes to simulate recombination at each of one or more genetic loci. Two virtual gametes from the two respective potential parents may be combined to generate a genetic sequence of a virtual progeny.
Once the virtual progeny is simulated, alleles or mutations in the virtual progeny may be assigned the one or more of the likelihoods or scores determined for corresponding alleles or mutations in aligned loci of the multiple extant organisms. These likelihoods may indicate the potential or probability that the virtual progeny's alleles or mutations would be deleterious, for example, if those alleles or mutations were found in the genome of a living organism such as a human child.
The subject matter regarded as the invention is particularly pointed out and distinctly claimed in the concluding portion of the specification. The invention, however, both as to organization and method of operation, together with objects, features, and advantages thereof, may best be understood by reference to the following detailed description when read with the accompanying drawings in which:
It will be appreciated that for simplicity and clarity of illustration, elements shown in the figures have not necessarily been drawn to scale. For example, the dimensions of some of the elements may be exaggerated relative to other elements for clarity. Further, where considered appropriate, reference numerals may be repeated among the figures to indicate corresponding or analogous elements.
In the following description, various aspects of the present invention will be described. For purposes of explanation, specific configurations and details are set forth in order to provide a thorough understanding of the present invention. However, it will also be apparent to one skilled in the art that the present invention may be practiced without the specific details presented herein. Furthermore, well known features may be omitted or simplified in order not to obscure the present invention.
Unless specifically stated otherwise, as apparent from the following discussions, it is appreciated that throughout the specification discussions utilizing terms such as “processing,” “computing,” “calculating,” “determining,” or the like, refer to the action and/or processes of a computer or computing system, or similar electronic computing device, that manipulates and/or transforms data represented as physical, such as electronic, quantities within the computing system's registers and/or memories into other data similarly represented as physical quantities within the computing system's memories, registers or other such information storage, transmission or display devices.
Embodiments of the invention relate to multiple types of genetic sequences:
As used herein, a “genetic sequence” may include genetic information representing one or more bases, nucleotides or alleles (sequences of nucleotides defining different forms of a gene) for any number of sequential or non-sequential genetic loci. For example, a “genetic sequence” may refer to allele information at a single genetic locus, or multiple genetic loci, such as, one or more gene segments or an entire genome. A genetic sequence is a data structure representing genetic information at one or more loci of a real or virtual genome. Genetic sequence data structures may include, for example, one or more vectors, scalar values, functions, sequences, sets, matrices, tables, lists, arrays, and/or other data structures, representing one or more bases, nucleotides, genes, alleles, codons or other generic material. The data structures representing each single chromosome sequence may be one dimensional (e.g., representing a single base or allele per locus) or multi-dimensional (e.g., representing multiple or all bases A,T,C,G or alleles at each locus and a probability associated with the likelihood of each existing in a potential progeny). The same (or different) data structures may be used for real and virtual genome sequences, though real genome sequences generally represent real genetic material (e.g., DNA extracted from a currently or previously existing genetic sample), while virtual genome sequences have no real corresponding genetic material (e.g., the sequence may represent an imaginary non-existing gamete, progeny, etc.).
According to some embodiments of the invention, multiple reference genetic sequences from multiple extant organisms within one species (“single-species” model) or multiple different species (“multi-species” model) may be used to generate an evolutionary model to predict deleterious allele mutations in virtual progeny. In one example of a multi-species model, multiple different vertebrate species may be used to predict deleterious allele mutations in virtual human progeny.
The reference genetic sequences may be aligned to link or associate one or more genetic loci in each of the multiple different sequences. Aligned loci of the different sequences may be derived from one or more common ancestral genetic loci and/or may relate to the same features, diseases or traits. A measure of evolutionary variation of alleles at one or more of the aligned genetic loci may be computed, for example, as a function of variation in alleles at corresponding aligned genetic loci in the multiple aligned reference genetic sequences. Aligned genetic loci associated with a relatively lower frequency of allele variation may indicate that the alleles are “functional” or relatively important to an organism's survival and their mutations may have a relatively higher likelihood of causing deleterious traits in an organism, whereas aligned genetic loci associated with a relatively higher frequency of allele variation in the reference genetic sequences may indicate that the alleles are less or non-functional and may be mutated with a relatively lower likelihood of impacting the survival or formation of deleterious traits in an organism. In some embodiments, the reference genetic sequences in the model may be weighted according to their evolutionary proximity of its population or species to the population or species of the virtual progeny and potential parent. For example, more weight may be assigned to reference genetic sequences of populations or species that are relatively more evolutionarily related (e.g., closer on a phylogenetic tree or having a relatively smaller Hamming distance).
Genetic sequences may be obtained from two potential parents, such as, two individuals that plan on mating or between one individual seeking a genetic donor and each of a plurality of candidates from a pool of genetic donors. The potential parents' genetic sequences may be obtained from genetic samples of biological material from the potential parents. A mating may be simulated between two potential parents, for example, by combining the genetic information from the two potential parents' genetic sequences to generate one or more genetic sequences of simulated virtual progeny.
The virtual progeny genetic sequences may be aligned with one or more of the reference genetic sequences to identify one or more alleles that evolved from the same ancestral genetic loci. The virtual progeny may be assigned one or more of the likelihoods of exhibiting deleterious traits associated with one or more alleles or mutations in the virtual progeny genetic sequences based on the measure of evolutionary variation of alleles at the corresponding aligned genetic loci in the reference genetic sequences.
Embodiments of the invention overcome the limitations of relying on specific information derived from human or cellular studies of the effect of mutation in order to score the propensity or probability that a particular mutation or allele will cause a deleterious phenotype, trait or disease.
An insight recognized according to embodiments of the invention is that extant genetic variation, that is existing or surviving genetic variation present amongst homologous or paralogous reference DNA sequences present in different organisms or members of a population, represents the outcome of an experiment that can be informative for predicting whether a given mutation or allele variation in a prospective parent's genome is likely to be deleterious to their child.
This experiment is the process of evolution, which has governed the replication and diversification of life on Earth. Today, there are many species, and individuals within a species all contain copies of genetic material which is derived from common ancestral versions. As species and individuals reproduce and copy their DNA, mutations appear which make these descendent copies distinct from the parental versions. The eventual fate of such new mutations, whether they will continue to be passed along to offspring or eventually die out, is determined by a stochastic process that is influenced by the mutation's effect on the reproductive fitness of the organism. Mutations that have no functional effect (neutral mutations) or are beneficial to an organism (positive mutations) are more likely to eventually increase in frequency and persist in the population, increasing diversity or replacing their parental version. In contrast, mutations which lower the reproductive fitness of an organism (negative or deleterious mutations) are unlikely to persist and contribute to future genetic variation.
Over the course of evolutionary time, a great many mutations have appeared and persisted, leading to the present diversity amongst DNA sequences derived from a common ancestor. However, this diversity is not equally distributed amongst all sequence positions in a genome. Although mutations are essentially introduced during the replication process independent of any functional effect they may have, the evolutionary filtering process is greatly influenced by such effects. As such, when comparing the genomes of several species or individuals today, we see that some areas are conserved (such as having the same coding sequence and/or non-coding sequence), while others have much more greatly diverged (having very diverged sequences from each other or relative to the ancestral copy number).
Reference is made to
A multiple sequence alignment of present day reference genetic sequences may be derived from common ancestral genetic loci of multiple species (e.g. different vertebrate sequenced genomes) or multiple individuals within a single species (e.g. a collection of human sequences). A substantially large sample size of organisms, populations or species (e.g., tens, hundreds, or more) may be used for statistically significant likelihoods, for example, to reduce bias error due to a skewed sample set.
Embodiments of the invention may compute a measure of evolutionary variation of alleles f at each of one or more aligned genetic loci as a function of variation in alleles F at corresponding aligned genetic loci in the multiple sequence alignment (MSA). The measure of evolutionary variation of alleles f may be transformed into a likelihood or score s associated with a relative propensity that this allele mutation would be damaging if produced in a child. This likelihood or score s may be derived, for example, using two functional transformations F and S, to convert columns of aligned genetic loci of a multiple sequence alignment (MSA) and a putative mutation or allele in a virtual progeny into a propensity score or likelihood s relevant to assessing the effect of that particular allele or mutation on the virtual progeny, for example, as shown in equation (1):
Multiple Sequence Alignment (MSA)→f=F(MSA)→s=S(f) (1)
The first functional transformation shown in equation (1), f=F(MSA), is used to compute a measure of evolutionary variation of alleles f at each of one or more genetic loci derived from one or more common ancestral genetic loci in the multiple organisms as a function of variation in alleles F at corresponding aligned genetic loci in the multiple aligned genetic sequences. The first functional transformation may create a raw score that quantifies the relative amount of sequence conservation at the one or more genetic loci. There are many possible instantiations of this function that may be used according to embodiments of the invention. For example, one such function may input information from the DNA or amino acid genetic sequences present in the alignment and output a Shannon entropy of the sequence characters at each of the one or more genetic loci. Denoting a frequency of a particular symbol (DNA base or amino acid) at a particular genetic locus or column position, (j), in a multiple sequence alignment as Pi, i={A, C, G, T} (for DNA, or the set of amino acid symbols if considering a protein alignment), the Shannon entropy function may be calculated, for example, as shown in equation (2):
F(MSAj)=Σipi·log2pi (2)
Another example of the first functional transformation shown in equation (1), f=F (MSA), may take the average pairwise difference between different symbols (S) in an aligned sequence column of length N, for example, as in equation (3):
Other possible functional forms of the first functional transformation, F(MSA), may calculate a distance metric from a particular species or sequence in the reference alignment. For example, the function may rank all the sequences in the alignment according to their Hamming distance from the reference (e.g., human) sequence, and then calculate the rank of the first sequence with a divergent symbol at the relevant position in the alignment, or if ranking a particular mutation, the rank of the first sequence matching that particular mutation. Additional functional forms such as not using the ordinal rankings of sequences by Hamming distance, but instead using the Hamming distance itself as the metric may be used.
Additionally, the function F(MSA) need not return a single value or be a function of a single column in the multiple sequence alignment. The function may be a composite function of one or more of the functions previously described in addition to others (e.g., F1, F2, F3, . . . ), and may output a vector of values (e.g., (s1, s2, s3, . . . )) rather than a single value. The function may also take as input multiple columns (j), or even the entire alignment, when calculating the value(s), f, and may also take as input a particular mutation under consideration, which may or may not affect the calculation of the values returned by the function.
The second functional transformation specified by equation (1), s=S(f), is a function which converts the measure of evolutionary variation of alleles into a relative propensity or likelihood of being damaging. Many possible instantiations of this function are also possible. For example, a function s=S(f) may score the value(s) of f according to its ranking in the empirical distribution of values for all mutations or alleles considered, or that could be considered, based on a collection of multiple reference sequence alignments. Other scoring methods may also be used. For example, a function trained to discriminate mutations in a database of known or suspected to be damaging alleles from neutral alleles may be used to assess the likelihood of damage (e.g., using any variety of statistical models or derived variants from experimental findings), or a function which is trained to assess the likelihood of a mutation reaching a certain frequency in the population. In all cases, this functional transformation, in combination with the first, allows particular genetic allele mutations to be ranked and assessed for likelihood of survival or damage if produced in a child.
Embodiments of the invention may model the phylogenetic history of the multiple reference aligned genetic sequences (MSA) for the purpose of assessing the likelihood of damaging effects of an allele mutation in a new organism.
Because DNA replication is semi-conservative, the evolutionary history of a DNA molecule may be represented by a bifurcating tree, known as a “phylogenetic” tree, that represents the known or inferred historical or evolutionary relationships between present day extant reference genetic sequences. A large body of scientific literature has developed over the past 30 years that studies the problem of inferring this tree from present day sequences. Typically, such models envision the evolutionary process between nodes of the tree as being similar to a general time reversible (GTR) Markov chain. In these models, in an interval of time, t, there is a certain probability that a base in the sequence will mutate, or transition to another base (e.g., A→C). Such models may be described using a transition matrix that describes the relative probability of transition from one base to another, for example, as shown in equation (4):
In equation (4) above, the elements of the transition matrix Q define a probability that each base denoted by the row will transition to each base denoted by the column, for example, in an infinitely small evolutionary time interval Δt. Note that the diagonal terms in the transition matrix are not shown, as they are simply equal to one minus the other elements in the row (the probabilities of the elements in each row sum to 1). The πi terms represent the equilibrium frequency of the nucleotide bases {i=A, C, G, T}, and the symbols a, b, c, d, e and f are parameters that further govern the substitution dynamics. This matrix represents a generalized time-reversible model, in which each rate below the diagonal equals a reciprocal rate above the diagonal multiplied by the equilibrium ratio of the two bases. Equation (4) is only one example of a substitution matrix used for phylogenetic inference.
Reference is made to
After fitting the Markov model that accounts for the phylogenetic history of the sequence alignment, whether using a Bayesian approach or maximum likelihood approach, embodiments of the invention may provide not only an inferred phylogenetic tree, but also a model for the evolutionary process of the multiple reference sequences in that tree.
Embodiments of the invention may use this evolutionary model to directly assess the likelihood that a mutation is damaging by examining the probability that a mutation found in a parent's genome persists into the future. That is, rather than using the model to infer the past history of evolution, the model is trained using the outcomes of the past and then used to calculate the likelihood of an allele persisting into the future. Because this likelihood is directly related to the probability that the allele is damaging (less likely mutations being more likely to be damaging), this phylogenetic approach, which directly accounts for the past history of the sequence in a parametric model, is a uniquely valuable functional form for the F(MSA) specified by equation (1).
Important extensions to the phylogenetic model are those which either change the model to account for sequence context (e.g., information about sequence location or what a sequence encodes, such as, methylation or homopolymer status) and functional effect (e.g., synonymous vs. non-synonymous, or affecting or not affecting expression), or that partition the sequence in some way to account for varying rates of substitutions, for example, based on the location of loci in the genome.
To account for varying rates of substitutions, for example, instead of the direct application of the substation rate matrix in equation (4) to all sequence substitutions, an alternate model may specify that although the relative rates of different types of substitutions at all alignment positions was governed by (4), the global rate at each site (that is the total mutation rate, denoted μ), may vary across sites or loci in the genome. A multitude of such models are possible. For example, the rates at different genetic loci may be drawn from a parametric distribution, such as a Γ-distribution that is also fit during the modeling procedure, or the distribution of rates may be derived from several categories of possible distributions. In one embodiment, this model may specify two different distribution categories (such as, conserved or rapidly evolving categories) and then train the model to identify to which distribution category the observed sequence belongs, for example, using a hidden Markov procedure. In some embodiments of the invention, the inferred or posterior probability that a genetic locus or mutation belongs to a category in the phylogenetic model may be returned by the F(MSA) function instead of the likelihood itself.
To account for functional effects, the phylogenetic model used to form the likelihood for the F(MSA) function may directly account for the functional consequence of a mutation. For example, the coding sequence of a protein is determined by triplets of neighboring DNA nucleotides that form a functional unit referred to as a “codon.” A mutation in a nucleotide within a codon may either have a functional effect of changing the amino acid sequence encoded by that codon (in which case it is referred to as “non-synonymous” since the mutation encodes for a different amino acid sequence) or may be a substitution with no functional effect on the amino acid encoded due to the redundancy of the genetic code (in which case it is referred to as “synonymous” since the mutation encodes for the same amino acid sequence). The Markov model that may be used in predicting the likely damaging effect of a mutation may directly account for such functional effects. For example, the transition probability of mutating from nucleotide i to j specified by the ijth matrix Q element qij in equation (4), may be replaced by an instantaneous transition probability tij, for example, defined by equation (5).
This would allow a new instantaneous transition matrix, T, to be used in the model, and a new parameter, co, which is equal to the non-synonymous to synonymous substitution rate to be used in predicting the likelihood that an allele is damaging or that it persists into the future. In practice, the co parameter may be constant for an entire multiple sequence alignment, may be assigned to each codon position in the alignment by assuming they are drawn from some hierarchical distribution, or may be uniquely assigned to each codon position. The substitution model specified by equation (5) may also be altered to account for each combination of the 64×64 possible elements of a transition matrix representing the rate in which each of the 64 possible codons (e.g., the 43=64 different combinations of four nucleotide states (A, T, C, G) at three nucleotide positions in each codon) transition to each of the 64 possible codons. In all instantiations of the evolutionary model, the functional effect of a sequence change, whether on the amino acid, regulatory context or other biological context may be directly accounted for, and used to predict the likelihood that the allele was damaging.
Reference is made to
System 300 may include a genetic sequencer 302, a sequence analyzer 304 and/or a sequence aligner 306. Units 302-306 may be implemented in one or more computerized devices as hardware or software units, for example, specifying instructions configured to be executed by a processor. One or more of units 302-306 may be implemented as separate devices or combined as an integrated device.
Genetic sequencer 302 may input biological samples, such as, blood, tissue, or saliva, or information derived therefrom, of each real (living) potential parent and may output the potential parent's genetic sequence including the individual's genetic information at one or more genetic loci, for example, a human genome.
Sequence analyzer 304 may input two potential parent's genetic sequences to simulate a mating by combining genetic information therefrom and output a virtual progeny genetic sequence of a virtual gamete, for example, as described in reference to
Sequence aligner 306 may align one or more loci of the virtual progeny genetic sequence and a plurality of reference genetic sequences of extant organisms from one or more species.
Sequence analyzer 304 may input the multiple sequence alignment and may compute a measure f of evolutionary variation of alleles at one or more genetic loci, which may be transformed into one or more likelihoods or scores s associated with a relative propensity that these alleles would be damaging if produced in a child.
Genetic sequencer 302, sequence aligner 304, and sequence analyzer 306 may include one or more controller(s) or processor(s) 308, 310, and 312, respectively, configured for executing operations and one or more memory unit(s) 314, 316, and 318, respectively, configured for storing data such as genetic information or sequences and/or instructions (e.g., software) executable by a processor, for example for carrying out methods as disclosed herein. Processor(s) 308, 310, and 312 may include, for example, a central processing unit (CPU), a digital signal processor (DSP), a microprocessor, a controller, a chip, a microchip, an integrated circuit (IC), or any other suitable multi-purpose or specific processor or controller. Processor(s) 308, 310, and 312 may individually or collectively be configured to carry out embodiments of a method according to the present invention by for example executing software or code. Memory unit(s) 314, 316, and 318 may include, for example, a random access memory (RAM), a dynamic RAM (DRAM), a flash memory, a volatile memory, a non-volatile memory, a cache memory, a buffer, a short term memory unit, a long term memory unit, or other suitable memory units or storage units. Genetic sequencer 302, sequence aligner 304, and sequence analyzer 306 may include one or more input/output devices, such as output display 320 (e.g., such as a monitor or screen) for displaying to users results provided by sequence analyzer 306 and an input device 322 (e.g., such as a mouse, keyboard or touchscreen) for example to control the operations of system 300 and/or provide user input or feedback, such as, selecting one or more models or phylogenetic trees, selecting one or more genus or species to use for generating the models, selecting input genetic sequences, selecting two potential parents or multiple donor candidates from a pool of potential parents with which to simulate mating, selecting a number of iterations for simulating a mating with a different pair of virtual gametes in each iteration from each pair of potential parents, etc.
Reference is made to
For each of the two potential parents, a processor (e.g., sequence analyzer processor 312 of
The two virtual gamete haploid genetic sequences 406 and 408 for the two respective potential parents may be combined to simulate a mating between the first and second potential parents resulting in a virtual progeny diploid genetic sequence 410 (a discrete genome of a child potentially to be conceived).
Since the selection of alleles is at least partially random, this mating is just one of the many possible genetic combinations for the first and second potential parents. This process may be repeated multiple times (e.g., hundreds or thousands of times), each time following a different recombination path (e.g., a different sequence of alleles selected) for one or both of the potential parents, to generate multiple genetic permutations that are possible for mating the first and second potential parents. The virtual progeny diploid genetic sequence 410 may include a single (e.g., most probable) genetic sequence or a probability distribution of multiple possible sequences, for example, to indicate, for many possible matings, the overall likelihood of each of multiple alleles at each of one or more loci in a virtual or hypothetical progeny.
Embodiments of the invention may use methods for simulating a mating between two potential parents and generating a virtual progeny genetic sequence described in U.S. Pat. No. 8,805,620, which is incorporated herein by reference in its entirety. Other methods may also be used.
Once the virtual progeny genetic sequence 410 is generated, it may be aligned with one or more reference genetic sequences of one or more organisms in a multiple sequence alignment (MSA). Based on a measure of variation between organisms at the aligned genetic loci, the virtual progeny may be assigned one or more of the likelihoods that one or more alleles or mutations in the virtual genetic sequence 410 would be deleterious, for example, if replicated in a real living progeny.
Reference is made to
In operation 500, a processor (e.g., sequence analyzer processor 312 of
In operation 510, the processor may build or obtain a model representing measures of evolutionary variation of alleles or nucleotides at one or more aligned genetic loci between the multiple organisms. The model may be a single-species model (e.g., the multiple organisms are from the same single species) or a multi-species model (e.g., the multiple organisms are from different multiple species). The model may include, for example, a phylogenetic tree (e.g., as shown in
In operation 520, the processor may receive genetic sequences of two potential parents (e.g., potential parent genetic sequences 402 and 404 of
In operation 530, the processor may simulate a mating between the two potential parents by combining their genetic sequences to generate one or more virtual progeny genetic sequences (e.g., sequence 410 of
In operation 540, the processor may use the model of operation 500 defining the evolutionary past variation among multiple extant organisms of different populations or species to predict or interpolate a likelihood or probability of evolutionary health of the virtual progeny simulated in operation 530. The processor may determine the differences between the virtual progeny genetic sequence and one or more aligned reference genetic sequences and may assign each allele (or only different or mutated alleles) a measure of evolutionary variation that is a function of variations in alleles at corresponding aligned genetic loci in the multiple aligned genetic sequences (e.g., loci derived from one or more common ancestral genetic loci in the multiple organisms). The processor may compute one or more likelihoods that an allele mutation at each of the one or more genetic loci in the simulated virtual progeny will be deleterious based on the measure of evolutionary variation of alleles at the corresponding aligned genetic loci for the multiple organisms. The likelihoods may include one or more likelihoods or likelihood distributions for one or more alleles, one or more allele mutations, one or more genes, one or more codons, one or more genetic loci or loci segments, for one or more virtual progeny of two potential parents (e.g., generated by repeatedly simulating a mating using different virtual gamete(s) in each iteration) and/or for one or more pairs of potential parents (e.g., generated by repeatedly simulating a mating step, in each iteration using the genetic information of the same first one of the two potential parents and a different second one of the two potential parents iteratively selected from a plurality of genetic donor candidates). The one or more likelihoods may be compared to one or more thresholds or other statistical models to predict if (or a likelihood or degree in which) an allele mutation will be deleterious in the virtual progeny. For example, mutations at genetic loci with relatively constant or fixed alleles and relatively lower measures of evolutionary variation may be associated with relatively higher likelihoods of deleterious traits, whereas mutations at genetic loci with relatively volatile or changing alleles and relatively higher measures of evolutionary variation may be associated with relatively lower likelihoods of resulting in deleterious traits.
In operation 550, an output device (e.g., output device 320 of
Other or different operations or orders of operations may be used and operations may be repeated, e.g., until the likelihoods converge or asymptotically approach a statistically stable result.
In accordance with embodiments of the present invention and as used herein, the following terms are defined with the following meanings, unless explicitly stated otherwise.
As used herein, “haploid cell” refers to a cell with a single set (n) of unpaired chromosomes.
“Gametes”, as used herein, are specialized haploid cells (e.g., spermatozoa and oocytes) produced through the process of meiosis and involved in sexual reproduction.
As used herein, “diploid cell” has a homologous pair of each of its autosomal chromosomes, and has two copies (2n) of each autosomal genetic locus.
The term “chromosome”, as used herein, refers to a molecule of DNA with a sequence of base pairs that corresponds closely to a defined chromosome reference sequence of the organism in question.
The term “gene”, as used herein, refers to a DNA sequence in a chromosome that codes for a product (either RNA or its translation product, a polypeptide) or otherwise plays a role in the expression of said product. A gene contains a DNA sequence with biological function. The biological function may be contained within the structure of the RNA product or a coding region for a polypeptide. The coding region includes a plurality of coding segments (“exons”) and intervening non-coding sequences (“introns”) between individual coding segments and non-coding regions preceding and following the first and last coding regions respectively.
As used herein, “locus” refers to any segment of DNA sequence defined by chromosomal coordinates in a reference genome known to the art, irrespective of biological function. A DNA locus may contain multiple genes or no genes; it may be a single base pair or millions of base pairs.
As used herein, an “allele” is one of two or more existing genetic variants of a specific polymorphic genomic locus.
As used herein, “genotype” refers to the diploid combination of alleles at a given genetic locus, or set of related loci, in a given cell or organism. A homozygous subject carries two copies of the same allele and a heterozygous subject carries two distinct alleles. In the simplest case of a locus with two alleles “A” and “a”, three genotypes may be formed: A/A, A/a, and a/a.
As used herein, “genotyping” refers to any experimental, computational, or observational protocol for distinguishing an individual's genotype at one or more well-defined loci.
As used herein, “linkage disequilibrium” is the non-random association of alleles at two or more loci within a particular population. Linkage disequilibrium is measured as a departure from the null hypothesis of linkage equilibrium, where each allele at one locus associates randomly with each allele at a second locus in a population of individual genomes.
As used herein, a “genome” is the total genetic information carried by an individual organism or cell, represented by the complete DNA sequences of its chromosomes.
As used herein, a genetic “trait” is a distinguishing attribute of an individual, whose expression is fully or partially influenced by an individual's genetic constitution.
As used herein, “disease” refers to a trait that is at least partially heritable and causes a reduction in the quality of life of an individual person.
As used herein, a “phenotype” includes alternative traits which may be discrete or continuous. Phenotypes may include both traits and diseases.
As used herein, a “haplopath” is a haploid path laid out along a defined region of a diploid genome by a single iteration of a Monte Carlo simulation or a single chain generated through a Markov process. A haplopath is generated through the application of formal rules of genetics that describe the reduction of the diploid genome into haploid genomes through the natural process of meiosis. It may be formed by starting at one end of a personal chromosome or genome and walking from locus to locus, choosing a single allele at each step based on available linkage disequilibrium information, inter-locus allele association coefficients, and formal rules of genetics that describe the natural process of gamete production in a sexually reproducing organism.
A “virtual gamete” is a data structure representing an imaginary non-existing gamete, for example, simulated by at least partially randomly selecting genetic information from both chromosomes of a single potential parent genetic sequence. A virtual gamete may represent information selected along a single haplopath that extends across one or more loci, such as, an entire genome.
As used herein, a “virtual progeny genetic sequence” is a data structure representing the genetic information of an imaginary non-existing virtual progeny. The virtual progeny genetic sequence is, for example, a discrete genetic combination of two virtual gametes.
As used herein, a “variant” is a particular allele at a locus where at least two alleles have been identified.
As used herein, a “mutation” has the same meaning as a “mutant allele” which is a variant that causes a gene to function abnormally.
Embodiments of the invention may include an article such as a computer or processor readable non-transitory storage medium, such as for example a memory, a disk drive, or a USB flash memory device encoding, including or storing instructions, e.g., computer-executable instructions, which when executed by a processor or controller, cause the processor or controller to carry out methods disclosed herein.
Different embodiments are disclosed herein. Features of certain embodiments may be combined with features of other embodiments; thus certain embodiments may be combinations of features of multiple embodiments.
The foregoing description of the embodiments of the invention has been presented for the purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form disclosed. It should be appreciated by persons skilled in the art that many modifications, variations, substitutions, changes, and equivalents are possible in light of the above teaching. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the invention.
This patent application claims the benefit of U.S. patent application Ser. No. 14/568,456 filed Dec. 12, 2014, which claims benefit of U.S. provisional patent application No. 62/013,139, filed Jun. 17, 2014, both of which are incorporated by reference in its entirety.
| Number | Date | Country | |
|---|---|---|---|
| 62013139 | Jun 2014 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14568456 | Dec 2014 | US |
| Child | 14886520 | US |
